Home » UK and US in focus as Indian companies seeks $31 bn pharma exports in FY25

UK and US in focus as Indian companies seeks $31 bn pharma exports in FY25

UK and US in focus as Indian companies seeks  bn pharma exports in FY25

Premium

In 2022, the number of prescriptions filled by Americans rose to 6.7 billion, marking a 3.6 per cent increase from 2021, according to a report titled US-India Medicine Partnership: India’s Contribution to the US Healthcare System by IQVIA | File ima


As India seeks $31 billion in pharmaceutical exports in financial year 2024-25 (FY25), the United Kingdom (UK) and the United States (US) are its top targets.


India exported pharmaceutical products worth $27.9 billion in FY24, growing 9.6 per cent from the year before.


Udaya Bhaskar, director general of the Pharmaceutical Exports Promotion Council (Pharmexcil), said the group targets $1 billion in exports to the UK where demand for affordable generics is rising. “We were in the UK last month for meetings. We are also planning a road show in Belgium, the Netherlands, and the UK in November or so,” he

First Published: May 30 2024 | 3:47 PM IST